| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/13/2004 | DE10251170A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/13/2004 | CA2504213A1 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2004 | CA2503890A1 Mutagenesis methods using ribavirin and/or rna replicases |
| 05/13/2004 | CA2502833A1 Quaternary ammonium compounds and their use as antimuscarinic agents |
| 05/12/2004 | EP1418176A1 Pyrazole derivates, their preparation and their use in drugs |
| 05/12/2004 | EP1418175A1 Respiratory syncytial virus replication inhibitors |
| 05/12/2004 | EP1417202A2 Aminopiperidine derivatives as modulators of chemokine receptor activity |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417178A2 Heterocyclic amide derivatives and the use thereof as pesticides |
| 05/12/2004 | EP1417177A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 05/12/2004 | EP1341785A4 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 05/12/2004 | EP1200432B1 Amido spiropiperidines promote the release of growth hormone |
| 05/12/2004 | EP1063235B1 Benzofurylpyrone derivatives |
| 05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 05/12/2004 | EP1015441B1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
| 05/12/2004 | EP0910415B1 Fluoro-labelled anthracycline and anthracyclinone derivatives |
| 05/12/2004 | EP0891346B1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 05/12/2004 | CN1495177A C-10 position paclitaxane derivative and its medicine composition |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1495170A Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 05/12/2004 | CN1495169A Pyridine-3-carboxylic acid derivative |
| 05/12/2004 | CN1495164A Method for preparing chiral lactone |
| 05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
| 05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
| 05/12/2004 | CN1149212C Peperidine derivatives as reuptake inhibitors |
| 05/12/2004 | CN1149209C Triazole compounds with dopamine-D3-receptor affinity |
| 05/12/2004 | CN1149195C 5-HTIF agonists |
| 05/12/2004 | CN1149194C Process for preparation of spiro [(4-cyclohexanone)-[3H]indol]-2'[ih]-one derivs. |
| 05/12/2004 | CN1149193C Substituted tricyclic compound |
| 05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
| 05/12/2004 | CN1149082C Di-and trivalent small molecule selecting protein inhibitors |
| 05/11/2004 | US6734302 Cis-imidazolines |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734194 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 05/11/2004 | US6734191 Chemokine receptor binding heterocyclic compounds |
| 05/11/2004 | US6734182 Aryl sulfonamides and sulfamide derivatives and uses thereof |
| 05/11/2004 | CA2136999C Peripheral vasodilating agent containing piperidine derivative as active ingredient |
| 05/06/2004 | WO2004037820A1 Oxindole substituted piperazine derivatives |
| 05/06/2004 | WO2004037816A1 Benzofuran compounds having antitumor activity |
| 05/06/2004 | WO2004037815A1 Processes for producing optically active n-(2,3-epoxypropan-1-yl)phthalimide |
| 05/06/2004 | WO2004037809A1 Triazole compounds for the treatment of dysmenorrhoea |
| 05/06/2004 | WO2004037807A2 Medicinal arylethanolamine compounds |
| 05/06/2004 | WO2004037806A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them |
| 05/06/2004 | WO2004037805A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037787A1 1-phenylpyrrolidine-2-one-3-carboxamides |
| 05/06/2004 | WO2004037784A2 Pyrrolidones with anti-hiv activity |
| 05/06/2004 | WO2004037247A1 Oxindoles with anti-hiv activity |
| 05/06/2004 | WO2004037176A2 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 05/06/2004 | WO2004037171A2 Mitotic kinesin inhibitors |
| 05/06/2004 | WO2004037170A2 Process for making spirolactone compounds |
| 05/06/2004 | WO2004037169A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/06/2004 | WO2004037166A2 Therapeutic guanidines |
| 05/06/2004 | WO2004026822A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 05/06/2004 | WO2004018457A8 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 05/06/2004 | WO2004018451A8 Pyridazinone-derivatives as pde4 inhibitors |
| 05/06/2004 | WO2004005281A8 Inhibitors of tyrosine kinases |
| 05/06/2004 | WO2004004715A3 Novel delta opioid receptor ligands |
| 05/06/2004 | WO2003105779A3 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 05/06/2004 | WO2003097604A9 Pyridine carboxamide derivatives and their use as pesticides |
| 05/06/2004 | WO2003082853A8 New compounds |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | WO2002089800A3 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 05/06/2004 | WO2002020512A9 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 05/06/2004 | US20040087806 Processes for preparing 1,3-dioxolane nucleosides |
| 05/06/2004 | US20040087802 Process for preparing glycidylphthalimide |
| 05/06/2004 | US20040087798 Novel amide compounds |
| 05/06/2004 | US20040087795 E.g., paroxetine by sulfonating a 4-fluorophenyl-3-methylol-N-hydrocarbylpiperidine with a sulfonyl chloride; reacting with a phenol such as sesamol; oxycarbonylation of the piperidine N group with a chloroformic acid; and cleavage |
| 05/06/2004 | US20040087789 Treating Alzheimer's disease, peripheral neuropathy, seizure disorder and/or diabetes |
| 05/06/2004 | US20040087647 Enzyme inhibitors; prevent thrombosis; anticoagulants |
| 05/06/2004 | US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 05/06/2004 | US20040087637 Antiserotonine agents; central nervous system disorders |
| 05/06/2004 | US20040087628 Enzyme inhibitors; antiarthritic agents; psoriasis; viricides; bactericides |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087626 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
| 05/06/2004 | US20040087625 Dietetics; antilipemic agents; anticholesterol agents; reducing triglycerides |
| 05/06/2004 | US20040087623 Pyrazole derivatives against tgf overexpression |
| 05/06/2004 | US20040087601 Pyrimidine derivatives as IL-8 receptor antagonists |
| 05/06/2004 | US20040087588 Parp inhibitors |
| 05/06/2004 | US20040087584 Antiinflammatory agents; cognition activators; asthma therapy; antiarthritic agents; side effect reduction |
| 05/06/2004 | US20040087581 Heterocyclylalkylamines as muscarinic receptor antagonists |
| 05/06/2004 | US20040087575 Therapeutic chromone compounds |
| 05/06/2004 | US20040087568 Substituted anthranilic amide derivatives and methods of use |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040087548 Anticancer agents and treating immune disorders |
| 05/06/2004 | US20040087547 Orally administered antitumor agents |
| 05/06/2004 | US20040086746 Organic light emitting diode and organic luminescent materials thereof |
| 05/06/2004 | US20040083558 Oxidation hair color dyes, with properties as bright, chromatic, weatherproofing, wash and wear, chemical resistance |
| 05/06/2004 | EP1415995A2 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/06/2004 | EP1415990A1 Diazepan derivatives useful as factor X inhibitor |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1415986A1 Spiro compounds |
| 05/06/2004 | EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/06/2004 | EP1414814A1 6-aryl-4-aminopicolinates and their use as herbicides |
| 05/06/2004 | EP1414813A1 1,2,4-trioxolane antimalarials |